Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 18, 2013

Primary Completion Date

August 25, 2016

Study Completion Date

October 16, 2017

Conditions
Dysphagia
Interventions
PROCEDURE

Dilation

Dilation will be performed by either dilation balloons or over the wire polyvinyl dilators based upon the physician's discretion. Fluoroscopy may be used to aid in endoscopic dilation at the physician's discretion.

OTHER

Triamcinolone Injection

Triamcinolone is a generic name of a long-acting synthetic corticosteroid and approved for sale in the United States by the U.S. Food and Drug Administration (FDA). After endoscopic dilation is performed, a total of 40-80 mg (physician preference) of triamcinolone (40 mg/ml) will be injected throughout the stricture under direct visualization.

PROCEDURE

Esophagogastroduodenoscopy (EGD)

EGD is a test to examine the lining of the esophagus (the tube that connects your throat to your stomach), stomach, and first part of the small intestine. It is done with a small camera (flexible endoscope) that is inserted down the throat.

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

All Listed Sponsors
lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT01873573 - Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection | Biotech Hunter | Biotech Hunter